05:13 AM EST, 11/25/2025 (MT Newswires) -- Autolus Therapeutics ( AUTL ) said Tuesday that the National Institute for Health and Care Excellence has recommended leukemia drug Aucatzyl for use in the National Health Service in England and Wales to treat adult patients.

The company said it plans to launch the drug in England and Wales "imminently."

Autolus also plans to pursue patient access to the drug through the Scottish Medical Consortium, it said.